Document is current

Any future updates will be listed below

Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Crossref DOI link: https://doi.org/10.1007/s40273-023-01315-1

Published Online: 2023-09-04

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark